Works matching DE "CETUXIMAB"

Results: 1712
    1

    Targeting KRAS in colorectal cancer (Review).

    Published in:
    Molecular & Clinical Oncology, 2025, v. 23, n. 3, p. N.PAG, doi. 10.3892/mco.2025.2873
    By:
    • Zhang, Minjie;
    • Wu, Dawei;
    • Tang, Yu;
    • Zhang, Li;
    • Zhang, Shuquan;
    • Li, Wei;
    • Li, Ning;
    • Yan, Xinhua
    Publication type:
    Article
    2

    Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

    Published in:
    PLoS Medicine, 2024, v. 21, n. 5, p. 1, doi. 10.1371/journal.pmed.1004389
    By:
    • Wang, De-Shen;
    • Ren, Chao;
    • Li, Shan-Shan;
    • Fong, William Pat;
    • Wu, Xiao-Jun;
    • Xiao, Jian;
    • Li, Bin-Kui;
    • Zheng, Yun;
    • Ding, Pei-Rong;
    • Chen, Gong;
    • Qiu, Miao-Zhen;
    • Wang, Zhi-Qiang;
    • Wang, Feng-Hua;
    • Luo, Hui-Yan;
    • Wang, Feng;
    • Wang, Xiao-Zhong;
    • Wang, Ling-Yun;
    • Xie, De-Jin;
    • Chen, Tao;
    • Li, Li-Ren
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Can cetuximab affect paraneoplastic myopathy?

    Published in:
    Journal of Neuro-Oncology, 2009, v. 93, n. 3, p. 437, doi. 10.1007/s11060-009-9795-6
    By:
    • Eleni Galani;
    • Anastasios Bonakis;
    • Christos Christodoulou;
    • George Klouvas;
    • Drougou Angeliki;
    • Dimostenis Skarlos
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16

    Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2995, doi. 10.1007/s00432-021-03872-4
    By:
    • Kim, Sang-A;
    • Park, Hyejoo;
    • Kim, Kui-Jin;
    • Kim, Ji-Won;
    • Sung, Ji Hea;
    • Nam, Milang;
    • Lee, Ju Hyun;
    • Jung, Eun Hee;
    • Suh, Koung Jin;
    • Lee, Ji Yun;
    • Kim, Se Hyun;
    • Lee, Jeong-Ok;
    • Kim, Jin Won;
    • Kim, Yu Jung;
    • Kim, Jee Hyun;
    • Bang, Soo-Mee;
    • Lee, Jong Seok;
    • Lee, Keun-Wook
    Publication type:
    Article
    17
    18

    PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 6, p. 1803, doi. 10.1007/s00432-020-03458-6
    By:
    • In, Gino K.;
    • Vaidya, Poorva;
    • Filkins, Alexandra;
    • Hermel, David J.;
    • King, Kevin G.;
    • Ragab, Omar;
    • Tseng, William W.;
    • Swanson, Mark;
    • Kokot, Niels;
    • Lang, Julie E.;
    • Menendez, Lawrence;
    • DeClerck, Brittney;
    • Kim, Gene;
    • Hu, Jenny C.;
    • Terando, Alicia;
    • Jadvar, Hossein;
    • Ricker, Charité;
    • Miller, Kimberly A.;
    • Peng, David H.;
    • Wysong, Ashley
    Publication type:
    Article
    19
    20
    21

    Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 6, p. 1023, doi. 10.1007/s00432-017-2344-3
    By:
    • Schimanski, Carl;
    • Staib, Frank;
    • Göhler, Thomas;
    • Hebart, Holger;
    • Heike, Michael;
    • Neise, Michael;
    • Rudi, Jochen;
    • Geer, Thomas;
    • Dingeldein, Gerrit;
    • Lang, Claudia;
    • Ehscheidt, Peter;
    • Flohr, Thomas;
    • Josten, Klaus;
    • Karthaus, Meinolf;
    • Schmittel, Alexander;
    • Wierecky, Jan;
    • Boller, Emil;
    • Indorf, Martin;
    • Wörns, Marcus-Alexander;
    • Galle, Peter
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.

    Published in:
    2017
    By:
    • Taieb, Julien;
    • Le Malicot, Karine;
    • Shi, Qian;
    • Penault-Llorca, Frédérique;
    • Bouché, Olivier;
    • Tabernero, Josep;
    • Mini, Enrico;
    • Goldberg, Richard M.;
    • Folprecht, Gunnar;
    • Van Laethem, Jean Luc;
    • Sargent, Daniel J.;
    • Alberts, Steven R.;
    • Emile, Jean Francois;
    • Puig, Pierre Laurent;
    • Sinicrope, Frank A.;
    • Penault Lorca, Frédérique;
    • Bouché, Olivier;
    • Luc Van Laethem, Jean;
    • Francois Emile, Jean;
    • Laurent Puig, Pierre
    Publication type:
    journal article
    39
    40
    41
    42
    43
    44
    45

    Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma.

    Published in:
    Journal of Experimental Therapeutics & Oncology, 2017, v. 12, n. 3, p. 223
    By:
    • Kulason, Kay O.;
    • Schneider, Julia R.;
    • Chakraborty, Shamik;
    • Filippi, Christopher G.;
    • Pramanik, Bidyut;
    • Tamika Wong;
    • Fralin, Sherese;
    • Tan, Karissa;
    • Ray, Ashley;
    • Alter, Rachel A.;
    • Ortiz, Rafael;
    • Demopoulos, Alexis;
    • Langer, David J.;
    • Boockvar, John A.
    Publication type:
    Article
    46
    47
    48

    Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development.

    Published in:
    eLife, 2023, p. 1, doi. 10.7554/eLife.73288
    By:
    • Barber, Paul R.;
    • Mustapha, Rami;
    • Flores-Borja, Fabian;
    • Alfano, Giovanna;
    • Ng, Kenrick;
    • Weitsman, Gregory;
    • Dolcetti, Luigi;
    • Mohamed, Ali Abdulnabi;
    • Wong, Felix;
    • Vicencio, Jose M.;
    • Galazi, Myria;
    • Opzoomer, James W.;
    • Arnold, James N.;
    • Thavaraj, Selvam;
    • Kordasti, Shahram;
    • Doyle, Jana;
    • Greenberg, Jon;
    • Dillon, Magnus T.;
    • Harrington, Kevin J.;
    • Forster, Martin
    Publication type:
    Article
    49
    50